Case Report
Published on 13 Jul 2023
The tumor or inflammation? a case report on primary pulmonary choriocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1108798
- 1,385 views
- 1 citation
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,250 articles
Original Research
Published on 12 Jul 2023
Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1116809
- 2,070 views
- 3 citations
Original Research
Published on 12 Jul 2023
Predicting cancer relapse following lung stereotactic radiotherapy: an external validation study using real-world evidence
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1156389
- 1,906 views
- 2 citations
Case Report
Published on 10 Jul 2023
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1145986
- 4,592 views
- 4 citations
Case Report
Published on 10 Jul 2023
Small bowel edema and lymphocytic duodenitis as severe reversible gastrointestinal toxicity of selpercatinib in RET fusion–positive non–small cell lung cancer: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1201599
- 2,429 views
- 4 citations
Systematic Review
Published on 06 Jul 2023
Detection of KRAS mutation using plasma samples in non-small-cell lung cancer: a systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1207892
- 2,179 views
- 1 citation
Clinical Trial
Published on 05 Jul 2023
Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1217424
- 2,281 views
- 3 citations
Case Report
Published on 05 Jul 2023
Lung adenocarcinoma with bladder metastasis: A case report and literature review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1202885
- 4,292 views
- 1 citation
Original Research
Published on 05 Jul 2023
Leptospermum extract (QV0) suppresses pleural mesothelioma tumor growth in vitro and in vivo by mitochondrial dysfunction associated apoptosis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1162027
- 3,000 views
- 2 citations
Original Research
Published on 05 Jul 2023
A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1180723
- 3,989 views
- 7 citations
Original Research
Published on 05 Jul 2023
Detection of genomic mutations in blood and urine free circulating tumour DNA in patients with inoperable and metastatic lung adenocarcinoma harbouring an EGFR mutation in tissue: a UK pilot study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1197037
- 1,584 views
Original Research
Published on 04 Jul 2023
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1208204
- 4,390 views
- 7 citations
Original Research
Published on 04 Jul 2023
Camrelizumab as a novel third or post-third-line treatment strategy in small cell lung cancer: a retrospective study of 12 patients
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1180735
- 1,690 views
- 3 citations
Case Report
Published on 03 Jul 2023
Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1143775
- 2,088 views
Original Research
Published on 30 Jun 2023
A tumor mutational burden-derived immune computational framework selects sensitive immunotherapy/chemotherapy for lung adenocarcinoma populations with different prognoses
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1104137
- 3,360 views
- 9 citations
Case Report
Published on 28 Jun 2023
Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1182558
- 2,940 views
- 5 citations